AC
Armistice Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.5M | Sell |
100,032
-14,041
| -12% | -$7.37M | 0.91% | 9 |
|
|
2025
Q1 | $72.3M | Buy |
114,073
+86,028
| +307% | +$54.6M | 1.08% | 8 |
|
|
2024
Q4 | $20M | Buy |
28,045
+8,013
| +40% | +$5.71M | 0.27% | 70 |
|
|
2024
Q3 | $21.1M | Buy |
20,032
+7,968
| +66% | +$8.38M | 0.34% | 52 |
|
|
2024
Q2 | $12.7M | Sell |
12,064
-10,923
| -48% | -$11.5M | 0.16% | 82 |
|
|
2024
Q1 | $22.1M | Sell |
22,987
-37,013
| -62% | -$35.6M | 0.29% | 57 |
|
|
2023
Q4 | $52.7M | Sell |
60,000
-14,998
| -20% | -$13.2M | 0.72% | 22 |
|
|
2023
Q3 | $61.7M | Sell |
74,998
-49,002
| -40% | -$40.3M | 0.95% | 12 |
|
|
2023
Q2 | $89.1M | Buy |
124,000
+72,000
| +138% | +$51.7M | 1.29% | 8 |
|
|
2023
Q1 | $42.7M | Sell |
52,000
-58,000
| -53% | -$47.7M | 0.62% | 37 |
|
|
2022
Q4 | $79.4M | Sell |
110,000
-26,000
| -19% | -$18.8M | 1.38% | 14 |
|
|
2022
Q3 | $93.7M | Sell |
136,000
-52,000
| -28% | -$35.8M | 1.63% | 11 |
|
|
2022
Q2 | $111K | Buy |
188,000
+104,000
| +124% | +$61.5K | 1.94% | 9 |
|
|
2022
Q1 | $58.7M | Sell |
84,000
-32,000
| -28% | -$22.3M | 1.13% | 25 |
|
|
2021
Q4 | $73.3M | Buy |
116,000
+16,000
| +16% | +$10.1M | 1.2% | 17 |
|
|
2021
Q3 | $60.5M | Sell |
100,000
-56,000
| -36% | -$33.9M | 1.03% | 18 |
|
|
2021
Q2 | $87.1M | Sell |
156,000
-19,000
| -11% | -$10.6M | 1.56% | 11 |
|
|
2021
Q1 | $82.8M | Buy |
175,000
+43,000
| +33% | +$20.3M | 1.9% | 7 |
|
|
2020
Q4 | $63.8M | Buy |
132,000
+48,000
| +57% | +$23.2M | 2.17% | 6 |
|
|
2020
Q3 | $47M | Buy |
84,000
+16,000
| +24% | +$8.96M | 1.71% | 11 |
|
|
2020
Q2 | $42.4M | Buy |
68,000
+4,000
| +6% | +$2.49M | 1.86% | 13 |
|
|
2020
Q1 | $31.3M | Sell |
64,000
-36,000
| -36% | -$17.6M | 1.93% | 12 |
|
|
2019
Q4 | $37.5M | Sell |
100,000
-48,000
| -32% | -$18M | 2.17% | 6 |
|
|
2019
Q3 | $41.1M | Buy |
148,000
+24,000
| +19% | +$6.66M | 2.72% | 6 |
|
|
2019
Q2 | $38.8M | Buy |
+124,000
| New | +$38.8M | 2.45% | 7 |
|
|
2019
Q1 | – | Sell |
-70,000
| Closed | -$26.1M | – | 79 |
|
|
2018
Q4 | $26.1M | Sell |
70,000
-5,000
| -7% | -$1.87M | 1.98% | 14 |
|
|
2018
Q3 | $30.3M | Sell |
75,000
-53,000
| -41% | -$21.4M | 1.82% | 18 |
|
|
2018
Q2 | $44.2M | Buy |
128,000
+20,000
| +19% | +$6.9M | 2.88% | 4 |
|
|
2018
Q1 | $37.2M | Buy |
+108,000
| New | +$37.2M | 2.84% | 6 |
|
|
2017
Q4 | – | Sell |
-50,000
| Closed | -$22.4M | – | 72 |
|
|
2017
Q3 | $22.4M | Buy |
50,000
+6,000
| +14% | +$2.68M | 2.63% | 4 |
|
|
2017
Q2 | $21.6M | Buy |
44,000
+4,000
| +10% | +$1.96M | 2.75% | 5 |
|
|
2017
Q1 | $15.5M | Buy |
+40,000
| New | +$15.5M | 3.2% | 5 |
|